RPB

Editorial standards

Who writes, who reviews, how often, how corrections work, and what the evidence grades mean.

Standing disclaimer
Research Protocol Builder is an educational resource. Nothing on this site is medical advice. Peptides discussed here may be unapproved for human use in your jurisdiction. Always consult a qualified professional and your local regulations.
  1. 01

    Written

    Drafted in plain English from primary sources. Every figure carries a citation.

  2. 02

    Reviewed

    A medical or scientific reviewer checks every claim against the paper, not the abstract.

  3. 03

    Re-reviewed

    Every profile at least every 6 months, and whenever a notable paper is indexed.

  4. 04

    Translated

    Machine draft, then a bilingual reviewer with our terminology glossary. Stamped and dated.

  5. 05

    Corrected

    Errors are fixed, dated in page history and flagged for re-review in every language.

Evidence grades

Randomised controlled trials in humans.
Human, small or uncontrolled: case series, pilot, open-label.
Animal: in vivo animal studies only.
In vitro or theoretical: cell studies, mechanism inferred.
Anecdotal only: community reports, no published research.

Conflicts of interest

None. No writer or reviewer may hold a commercial interest in any compound or vendor covered here. Each reviewer’s statement is on the review board page.

Report an error

Every page links here. Corrections are dated in the page’s history panel.

Report an error

Licence

Profiles, guides and glossary are CC BY-NC-SA 4.0. Republish with attribution and a link back; nobody can sell it or strip the independence framing.